Age-Specific Cut-Off Levels of Anti-Müllerian Hormone as Diagnostic Markers for Polycystic Ovary Syndrome

    May 2021 in “ Reproductive Biology and Endocrinology ”
    Fahimeh Ramezani Tehrani, Maryam Rahmati, Fatemeh Mahboobifard … Fereidoun Azizi
    Studysummary This study found that using age-specific AMH cut-off levels can help better identify PCOS patients across different age groups from 20 to 40 years.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on rbej.biomedcentral.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Cardiometabolic Risks in Polycystic Ovary Syndrome: Long-Term Population-Based Follow-Up Study Fertility and Sterility · 2018
    2. The Prevalence of Polycystic Ovary Syndrome in a Normal Population According to the Rotterdam Criteria Versus Revised Criteria Including Anti-Mullerian Hormone Human Reproduction · 2014
    3. Phenotypic Comparison of Caucasian and Asian Women With Polycystic Ovary Syndrome: A Cross-Sectional Study Fertility and Sterility · 2013
    4. The Prevalence of Idiopathic Hirsutism and Polycystic Ovary Syndrome in the Tehran Lipid and Glucose Study Reproductive Biology and Endocrinology · 2011
    5. The Prevalence of Polycystic Ovary Syndrome in a Community Sample of Iranian Population: Iranian PCOS Prevalence Study Reproductive Biology and Endocrinology · 2011
    6. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report Fertility and Sterility · 2008
    7. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS) Human Reproduction · 2003